Michael Santos

Title: Michael Santos: Innovator in Pharmaceutical Formulations

Introduction

Michael Santos is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of tropomyosin-related kinase (TRK) inhibitors. With a total of 4 patents to his name, Santos continues to push the boundaries of innovation in medicine.

Latest Patents

Santos's latest patents focus on pharmaceutical formulations of tropomyosin-related kinase (TRK) inhibitors. These formulations include 3-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)-6-(1-methyl-1H-pyrazol-4-yl)-3H-imidazo[4,5-b]pyridin-2-amine in microcrystalline suspension formulations in its monohydrate form. This form shows improved characteristics over the anhydrate form and is also available in extended release formulations. The extended release pharmaceutical formulations comprise 3-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)-6-(1-methyl-1H-pyrazol-4-yl)-3H-imidazo[4,5-b]pyridin-2-amine-loaded microspheres.

Career Highlights

Michael Santos is currently employed at Genzyme Corporation, where he applies his expertise in pharmaceutical development. His work has been instrumental in advancing the understanding and application of TRK inhibitors in therapeutic settings.

Collaborations

Santos collaborates with esteemed colleagues such as Harvey Lieberman and Donglai Yang. Their combined efforts contribute to the innovative research and development at Genzyme Corporation.

Conclusion

Michael Santos is a prominent figure in the field of pharmaceutical innovations, particularly in the area of TRK inhibitors. His contributions through patents and collaborations highlight his commitment to advancing medical science.